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Helicobacter (H.) suis has been associated with chronic gastritis, gastric ulcer disease and 
decreased weight gain in pigs. This agent can also cause gastric disorders in humans. In this 
study, the immunogenicity and protective efficacy of three recombinant H. suis proteins (γ-
glutamyl transpeptidase, neutrophil-activating protein A and urease subunit B (rGGT, rNapA and 
rUreB)) were compared with those of H. suis whole-cell lysate (lysate) in a standardized mouse 
model. Mice were twice immunized intranasally with three weeks interval with either rGGT, 
rUreB, rNapA or lysate and subsequently intragastrically challenged with 10
8
 H. suis bacteria. 
Control groups consisted of non-immunized and non-challenged mice (negative control group), 
or of sham-immunized and challenged mice (positive control group). Mice were sacrificed four 
weeks after challenge. Bacterial colonization and stomach cytokine-expressions were examined 
with (RT)-qPCR. Serum immunoglobulin G (IgG) levels were determined by ELISA. Intranasal 
immunization of mice with lysate gave a clearance of infection in 50% of the animals and 
induced a specific anti-lysate IgG response. H. suis colonization in mice vaccinated with rGGT or 
rUreB was significantly (p<0.0001) lower compared to the positive control group and induced 
production of specific IgG. Immunization with rUreB resulted in a higher reduction of bacterial 
load compared to rGGT (100-fold and 10-fold reduction, respectively, compared with positive 
controls). rNapA had no significant (p=0.14) protective effect, although it induced anti-rNapA 
IgG. Expression of γ-interferon was significantly higher (p<0.05) in the stomach of animals 
vaccinated with rGGT, rUreB or lysate compared to non-vaccinated infected animals. Only 
vaccination with rGGT caused a significant (p<0.01) upregulation of TNF-α. All immunizations 
showed upregulation (p<0.05) of IL-17 mRNA, being most pronounced in the rGGT immunized 
group. In conclusion, immunization with recombinant H. suis proteins rGGT and rUreB could be 
promising for future vaccination of pigs against H. suis infections. 
